메뉴 건너뛰기




Volumn 13, Issue 8, 2004, Pages 537-545

Assessing teratogenicity of antiretroviral drugs: Monitoring and analysis plan of the Antiretroviral Pregnancy Registry

Author keywords

Antiretroviral therapy; Birth defects; Epidemiology; Pregnancy

Indexed keywords

ABACAVIR; ADEFOVIR DIPIVOXIL; AMPRENAVIR; AMPRENAVIR PHOSPHATE; ANTIRETROVIRUS AGENT; ATAZANAVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZALCITABINE; ZIDOVUDINE;

EID: 4544264072     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.982     Document Type: Article
Times cited : (23)

References (15)
  • 1
    • 0038754371 scopus 로고    scopus 로고
    • Food and Drug Administration (FDA). US Department of Health and Human Services, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research: Rockville, MD Available from [22 June 2004]
    • Food and Drug Administration (FDA). Guidance for Industry: Establishing Pregnancy Exposure Registries. US Department of Health and Human Services, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research: Rockville, MD, 2002. Available from URL: http://www.fda.gov/cber/gdlns/pregexp.pdf [22 June 2004].
    • (2002) Guidance for Industry: Establishing Pregnancy Exposure Registries
  • 3
    • 4644300482 scopus 로고    scopus 로고
    • Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2003
    • Antiretroviral Pregnancy Registry Steering Committee Registry Coordinating Center: Wilmington, NC Available from [22 June 2004]
    • Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2003. Registry Coordinating Center: Wilmington, NC, 2003. Available from URL: http://www.apregistry.com [22 June 2004].
    • (2003)
  • 5
    • 0141864516 scopus 로고    scopus 로고
    • The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention
    • Correa-Villasenor A, Cragan J, Kucik J, O'Leary L, Siffel C, Williams L. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res (Part A) 2003;67: 617-624.
    • (2003) Birth Defects Res. (Part A) , vol.67 , pp. 617-624
    • Correa-Villasenor, A.1    Cragan, J.2    Kucik, J.3    O'Leary, L.4    Siffel, C.5    Williams, L.6
  • 6
    • 0036750747 scopus 로고    scopus 로고
    • Birth defect classification by organ system: A novel approach to heighten teratogenic signalling in a pregnancy registry
    • Scheuerle A, Tilson H. Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry. Pharmacoepidemiol Drug Safe 2002; 11: 465-475.
    • (2002) Pharmacoepidemiol. Drug Safe , vol.11 , pp. 465-475
    • Scheuerle, A.1    Tilson, H.2
  • 7
    • 4544263666 scopus 로고    scopus 로고
    • Leading categories of birth defects
    • National Perinatal Statistics. March of Dimes Birth Defects Foundation. Available from [22 June 2004]
    • National Perinatal Statistics. Leading categories of birth defects. March of Dimes Birth Defects Foundation 2003. Available from URL: http://www.marchofdimes.com/aboutus/680_2164.asp [22 June 2004].
    • (2003)
  • 8
    • 0032806414 scopus 로고    scopus 로고
    • Evaluation of selected characteristics of pregnancy drug registries
    • Honein MA, Paulozzi LJ, Cragan JD, Correa A. Evaluation of selected characteristics of pregnancy drug registries. Teratology 1999;60: 356-364.
    • (1999) Teratology , vol.60 , pp. 356-364
    • Honein, M.A.1    Paulozzi, L.J.2    Cragan, J.D.3    Correa, A.4
  • 9
    • 0023153756 scopus 로고
    • Predictive value of minor anomalies. I. Association with major malformations
    • Leppig KA, Werler MM, Cann CI, Cook CA, Holmes LB. Predictive value of minor anomalies. I. Association with major malformations. J Pediatr 1987; 110: 531-537.
    • (1987) J. Pediatr. , vol.110 , pp. 531-537
    • Leppig, K.A.1    Werler, M.M.2    Cann, C.I.3    Cook, C.A.4    Holmes, L.B.5
  • 10
    • 0023029450 scopus 로고
    • Frequency of human congenital malformations
    • Oakley GP. Frequency of human congenital malformations. Clin Perinatol 1986; 13: 545-554.
    • (1986) Clin. Perinatol. , vol.13 , pp. 545-554
    • Oakley, G.P.1
  • 11
    • 0023734126 scopus 로고
    • Approximate interval estimation of the ratio of binomial parameters: A review and corrections for skewness
    • Gart JJ, Nam J. Approximate interval estimation of the ratio of binomial parameters: a review and corrections for skewness. Biometrics 1988; 44: 323-338.
    • (1988) Biometrics , vol.44 , pp. 323-338
    • Gart, J.J.1    Nam, J.2
  • 12
    • 0017053393 scopus 로고
    • The estimation and interpretation of attributable risk in health research
    • Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics 1976; 32: 829-849.
    • (1976) Biometrics , vol.32 , pp. 829-849
    • Walter, S.D.1
  • 13
    • 0003638014 scopus 로고    scopus 로고
    • Council for International Organizations of Medical Sciences (CIOMS) Working Groups III (revised) and V (new) (2nd edn). World Health Organization: Geneva, Switzerland
    • Council for International Organizations of Medical Sciences (CIOMS) Working Groups III (revised) and V (new). Guidelines for Preparing Core Clinical-Safety Information on Drugs (2nd edn). World Health Organization: Geneva, Switzerland, 1999.
    • (1999) Guidelines for Preparing Core Clinical-Safety Information on Drugs
  • 14
    • 4544303586 scopus 로고    scopus 로고
    • Antiretroviral Pregnancy Registry conforms with FDA Guidelines for Pregnancy Exposure Registries
    • APR Steering Committee
    • Covington DL, Doi PA, Tilson H, APR Steering Committee. Antiretroviral Pregnancy Registry conforms with FDA Guidelines for Pregnancy Exposure Registries. Pharmacoepidemiol Drug Safe 2003; 12(Suppl. 1): S22.
    • (2003) Pharmacoepidemiol Drug Safe , vol.12 , Issue.SUPPL. 1
    • Covington, D.L.1    Doi, P.A.2    Tilson, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.